Literature DB >> 8621806

Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters.

C Grunfeld1, C Zhao, J Fuller, A Pollack, A Moser, J Friedman, K R Feingold.   

Abstract

The expression of leptin, the ob gene product, is increased in adipose tissue in response to feeding and energy repletion, while leptin decreases food intake. Because adipose tissue gene expression is regulated by cytokines induced during infection and because infection is associated with anorexia, we tested whether induction of leptin might occur during the host response to infection. Administration of endotoxin (LPS), a model for gram negative infections, induces profound anorexia and weight loss in hamsters. In fasted adipose tissue to levels similar to fed control animals. There is a strong inverse correlation between mRNA levels of leptin and subsequent food intake. TNF and IL-1, mediators of the host response to LPS, also induced anorexia and increased levels of leptin in mRNA in adipose tissue. As assessed by immuknoprecipitation and Western blotting, circulating leptin protein is regulated by LPS and cytokines in parallel to regulation of adipose tissue leptin mRNA. Induction of leptin during the host response to infection may contribute to the anorexia of infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621806      PMCID: PMC507291          DOI: 10.1172/JCI118653

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Effect of centrally administered interleukin-1 and endotoxin on food intake of fasted rats.

Authors:  D O McCarthy; M J Kluger; A J Vander
Journal:  Physiol Behav       Date:  1986

Review 2.  New model for the regulation of energy balance and adiposity by the central nervous system.

Authors:  K J Kaiyala; S C Woods; M W Schwartz
Journal:  Am J Clin Nutr       Date:  1995-11       Impact factor: 7.045

Review 3.  Hypothalamic response to starvation: implications for the study of wasting disorders.

Authors:  M W Schwartz; M F Dallman; S C Woods
Journal:  Am J Physiol       Date:  1995-11

4.  Increased obese mRNA expression in omental fat cells from massively obese humans.

Authors:  B S Hamilton; D Paglia; A Y Kwan; M Deitel
Journal:  Nat Med       Date:  1995-09       Impact factor: 53.440

5.  Overexpression of the obese (ob) gene in adipose tissue of human obese subjects.

Authors:  F Lönnqvist; P Arner; L Nordfors; M Schalling
Journal:  Nat Med       Date:  1995-09       Impact factor: 53.440

6.  Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects.

Authors:  M Maffei; J Halaas; E Ravussin; R E Pratley; G H Lee; Y Zhang; H Fei; S Kim; R Lallone; S Ranganathan
Journal:  Nat Med       Date:  1995-11       Impact factor: 53.440

7.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

Authors:  R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245

8.  The role of neuropeptide Y in the antiobesity action of the obese gene product.

Authors:  T W Stephens; M Basinski; P K Bristow; J M Bue-Valleskey; S G Burgett; L Craft; J Hale; J Hoffmann; H M Hsiung; A Kriauciunas
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

9.  Transient increase in obese gene expression after food intake or insulin administration.

Authors:  R Saladin; P De Vos; M Guerre-Millo; A Leturque; J Girard; B Staels; J Auwerx
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

10.  Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells.

Authors:  J S Patton; H M Shepard; H Wilking; G Lewis; B B Aggarwal; T E Eessalu; L A Gavin; C Grunfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

View more
  156 in total

Review 1.  [Pathophysiology of catabolism in undernurished elderly patients].

Authors:  D Baez-Franceschi; J E Morley
Journal:  Z Gerontol Geriatr       Date:  1999-07       Impact factor: 1.281

Review 2.  New insights into the biology of the acute phase response.

Authors:  A F Suffredini; G Fantuzzi; R Badolato; J J Oppenheim; N P O'Grady
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

Review 3.  Hormonal regulation of physiological cell turnover and apoptosis.

Authors:  R D Medh; E B Thompson
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

Review 4.  Plasma leptin and exercise: recent findings.

Authors:  Matthew W Hulver; Joseph A Houmard
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

5.  Divergency of leptin response in intestinal inflammation.

Authors:  A Ballinger
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

6.  Leptin signaling and Alzheimer's disease.

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

7.  Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses.

Authors:  Veronica Sanna; Antonio Di Giacomo; Antonio La Cava; Robert I Lechler; Silvia Fontana; Serafino Zappacosta; Giuseppe Matarese
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

8.  Circulating leptin mediates lipopolysaccharide-induced anorexia and fever in rats.

Authors:  Christelle Sachot; Stephen Poole; Giamal N Luheshi
Journal:  J Physiol       Date:  2004-09-23       Impact factor: 5.182

Review 9.  Ghrelin and leptin pathophysiology in chronic kidney disease.

Authors:  Sujana S Gunta; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2012-12-11       Impact factor: 3.714

10.  Fatigue is associated with high circulating leptin levels in chronic hepatitis C.

Authors:  T Piche; E Gelsi; S M Schneider; X Hébuterne; J Giudicelli; B Ferrua; C Laffont; S Benzaken; P Hastier; M L Montoya; F Longo; P Rampal; A Tran
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.